Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 1,454 | 457 | 1,484 | 2,166 | 1,309 |
| Cost of Goods | 3,952 | 3,279 | 4,903 | 3,791 | 4,297 |
| Gross Profit | -2,498 | -2,822 | -3,419 | -1,625 | -2,988 |
| Operating Expenses | 5,718 | 7,497 | 8,833 | 7,969 | 6,666 |
| Operating Income | -7,264 | -10,040 | -11,349 | -8,803 | -9,357 |
| Interest Expense | 2,234 | 2,202 | 2,214 | 788 | 443 |
| Other Income | 2,791 | -1,086 | 7,601 | -1,144 | 4,108 |
| Pre-tax Income | -6,707 | -13,328 | -5,962 | -10,735 | -5,692 |
| Net Income Continuous | -6,707 | -13,328 | -5,962 | -10,735 | -5,692 |
| Net Income | $-6,707 | $-13,328 | $-5,962 | $-10,735 | $-5,692 |
| EPS Basic Total Ops | -0.34 | -0.77 | -0.34 | -0.62 | -0.30 |
| EPS Basic Continuous Ops | -0.33 | -0.77 | -0.34 | -0.62 | -0.29 |
| EPS Diluted Total Ops | -0.34 | -0.77 | -0.34 | -0.62 | -0.30 |
| EPS Diluted Continuous Ops | -0.33 | -0.77 | -0.34 | -0.62 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.50 | -0.71 | -0.62 | N/A | N/A |
| EBITDA(a) | $-5,738 | $-8,541 | $-9,844 | $-7,561 | $-8,226 |